Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ernesto Yagüe
Oncogenic EP300 Can Be Targeted With Inhibitors of Aldo-Keto Reductases
Biochemical Pharmacology
Biochemistry
Pharmacology
Related publications
Aldo-Keto Reductases 1B in Adrenal Cortex Physiology
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
Regulation of Aldo–Keto Reductases in Human Diseases
Frontiers in Pharmacology
Pharmacology
The Diversity of Microbial Aldo/Keto Reductases From Escherichia Coli K12
Chemico-Biological Interactions
Medicine
Toxicology
Aldo-Keto Reductases and Formation of Polycyclic Aromatic Hydrocarbon O-Quinones
Methods in Enzymology
Aldo-Keto Reductases Protect Metastatic Melanoma From ER Stress-Independent Ferroptosis
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Age-Dependent Change in Aldo-Keto Reductases Composition in the Blood of Rats
American Journal of Biomedical and Life Sciences
Roles of Rat and Human Aldo–keto Reductases in Metabolism of Farnesol and Geranylgeraniol
Chemico-Biological Interactions
Medicine
Toxicology
Aldo-Keto Reductases Protect Lung Adenocarcinoma Cells From the Acute Toxicity of B[a]P-7,8-Trans-Dihydrodiol
Chemical Research in Toxicology
Medicine
Toxicology
N-Benzoyl Anthranilic Acid Derivatives as Selective Inhibitors of Aldo–keto Reductase AKR1C3
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery